+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

From
From
Cervical Cancer Drugs Market Report 2026 - Product Thumbnail Image

Cervical Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Advanced Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cervical Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 160 Pages
  • Global
From
Cervical Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Cervical Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Monoclonal Antibody Collaboration and Licensing Deals 2019-2025

  • Report
  • November 2025
  • 400 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2026 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2026

  • Report
  • April 2026
  • 450 Pages
  • Global
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2026 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2026

  • Report
  • March 2026
  • 1200 Pages
  • Global
From
From
From
Glioma - Competitive Landscape, 2026 - Product Thumbnail Image

Glioma - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
Loading Indicator